Prophylaxis for stress-related gastrointestinal hemorrhage: A cost effectiveness analysis

Critical Care Medicine

Volumn 24, Issue 2, 1996, Pages 338-345

  Ben Menachem, Tamir ^a   McCarthy, Bruce D ^a   Fogel, Ronald ^a   Schiffman, Rhett M ^a   Patel, Rakesh V ^a   Zarowitz, Barbara J ^a   Nerenz, David R ^a   Bresalier, Robert S ^a  

^a HENRY FORD HOSPITAL   (United States)

Author keywords

cimetidine; cost effectiveness; critical illness; hemorrhage; intensive care unit; nosocomial pneumonia; prophylaxis; stomach; sucralfate

Indexed keywords

CIMETIDINE; SUCRALFATE;

ARTICLE; BLEEDING; COST BENEFIT ANALYSIS; COST EFFECTIVENESS ANALYSIS; DIAGNOSTIC ACCURACY; EMOTIONAL STRESS; GASTROINTESTINAL HEMORRHAGE; HIGH RISK POPULATION; HOSPITAL INFECTION; HUMAN; INTENSIVE CARE; PRIORITY JOURNAL; RISK ASSESSMENT;

ANTI-ULCER AGENTS; CIMETIDINE; COST-BENEFIT ANALYSIS; CROSS INFECTION; DECISION TREES; DRUG COSTS; GASTROINTESTINAL HEMORRHAGE; HUMANS; PNEUMONIA; PRIMARY PREVENTION; RISK; SENSITIVITY AND SPECIFICITY; STRESS; SUCRALFATE; TREATMENT OUTCOME;

EID: 0030059570     PISSN: 00903493     EISSN: None     Source Type: Journal    
DOI: 10.1097/00003246-199602000-00026     Document Type: Article

References (59)

1. Pingleton SK: Management of complications of acute respiratory failure. In: Pulmonary and Critical Care Medicine. Part R. Vol 11. Bone RC (Ed). St Louis, Mosby Year Book, 1993, pp 8-9
2. Wilcox CM, Spenney JG: Stress ulcer prophylaxis in medical patients: Who, what and how much? Am J Gastroenterol 1988; 83:1199-1211
3. Lacroix J, Infante-Rivard C, Jenicek M, et al: Prophylaxis of upper gastrointestinal bleeding in intensive care units: A meta-analysis. Crit Care Med 1989; 17: 862-869
4. Groll A, Simon JB, Wigle RD, et al: Cimetidine prophylaxis for gastrointestinal bleeding in an intensive care unit. Gut 1986; 27:135-140
5. McAlhany JC Jr, Czaja AJ, Pruitt BA Jr: Antacid control of complications from acute gastroduodenal disease after burns. J Trauma 1976; 16:645-649
6. MacDougall BRD, Bailey RJ, Williams R: H2-receptor antagonists and antacids in the prevention of acute gastrointestinal haemorrhage in fulminant hepatic failure: Two controlled trials. Lancet 1977; i:617-619
7. Hastings PR, Skillman JJ, Bushnell LS, et al: Antacid titration in the prevention of acute gastrointestinal bleeding. N Engl J Med 1978; 298:1041-1045
8. Schuster DP, Rowley H, Feinsten S, et al: Prospective evaluation of the risk of upper gastrointestinal bleeding after admission to a medical intensive care unit. Am J Med 1984; 76:623-630
9. Pinilla JC, Oleniuk FH, Reed D, et al: Does antacid prophylaxis prevent upper gastrointestinal bleeding in critically ill patients? Crit Care Med 1985; 13:646-650
10. van den Berg B, van Blankenstein M: Prevention of stress-induced upper gastrointestinal bleeding by cimetidine in patients on assisted ventilation. Digestion 1985; 31:1-8
11. Peura DA, Johnson LF: Cimetidine for prevention and treatment of gastroduodenal mucosal lesions in patients in an intensive care unit. Ann Intern Med 1985; 103:173-177
12. Lacroix J, Infant-Rivard C, Gauthier M, et al: Upper gastrointestinal tract bleeding acquired in a pediatric intensive care unit: Prophylaxis trial with cimetidine. J Pediatr 1986; 108:1015-1018
13. Karlstadt RG, Iberti TJ, Silverstein J, et al: Comparison of cimetidine and placebo for the prophylaxis of upper gastrointestinal bleeding due to stress-related gastric mucosal damage in the intensive care unit. Journal of Intensive Care Medicine 1990; 5:26-32
14. Reusser P, Gyr K, Scheidegger D, et al: Prospective endoscopic study of stress erosions and ulcers in critically ill neurosurgical patients: Current incidence and effect of acid-reducing prophylaxis. Crit Care Med 1990; 18: 270-273
15. Ruiz-Santana S, Ortiz E, Gonzalez B, et al: Stress-induced gastroduodenal lesions and total parenteral nutrition in critically ill patients: Frequency, complications, and the value of prophylactic treatment. A prospective, randomized study. Crit Care Med 1991; 19:887-891
16. Cook DJ, Pearl RG, Cook RJ, et al: The incidence of clinically important bleeding in ventilated patients. Journal of Intensive Care Medicine 1991; 6:167-174
17. Lacroix J, Nadeau D, Laberge S, et al: Frequency of upper gastrointestinal bleeding in a pediatric intensive care unit. Crit Care Med 1992; 20:35-42
18. Cochran EB, Phelps SJ, Tolley EA, et al: Prevalence of, and risk factors for, upper gastrointestinal tract bleeding in critically ill pediatric patients. Crit Care Med 1992; 20:1519-1523
19. Martin LF, Booth FV, Karlstadt RG, et al: Continuous intravenous cimetidine decreases stress-related upper gastrointestinal hemorrhage without promoting pneumonia. Crit Care Med 1993; 21:19-30
20. Cook DJ, Fuller HD, Guyatt GH, et al: Risk factors for gastrointestinal bleeding in critically ill patients. N Engl J Med 1994; 330:377-381
21. Ben-Menachem T, Fogel R, Patel RV, et al: Prophylaxis for stress-related gastric hemorrhage in the medical intensive care unit: A randomized, controlled, single-blind study. Ann Intern Med 1994; 121:568-575
22. Driks MR, Craven DE, Celli BR, et al: Nosocomial pneumonia in intubated patients given sucralfate as compared with antacids or histamine type 2 blockers. N Engl J Med 1987; 317:1376-1382
23. Tryba M: Prophylaxis of stress ulcer bleeding, a meta-analysis. J Clin Gastroenterol 1991; 13(Suppl 2):S44-S55
24. Schuster DP: Stress ulcer prophylaxis: In whom? With what? Crit Care Med 1993; 21:4-6
25. Peterson WL: Prevention of upper gastrointestinal bleeding. N Engl J Med 1994; 330:428-429
26. Peura DA, Koretz RL: Prophylactic therapy of stress-related mucosal damage: Why, which, who, and so what? Am J Gastroenterol 1990; 85:935-937
27. Tryba M, Kulka PJ: Critical care pharmacotherapy, a review. Drugs 1993; 45:338-352
28. Zuckerman GR, Cort C, Shuman RB: Stress ulcer syndrome. Journal of Intensive Care Medicine 1988; 3:21-31
29. Cook DJ, Witt LG, Cook RJ, et al: Stress ulcer prophylaxis in the critically ill: A meta-analysis. Am J Med 1991; 91: 519-527
30. Porter JB, Beard K, Walker AM, et al: Intensive hospital monitoring study of intravenous cimetidine. Arch Intern Med 1986; 146:2237-2239
31. Richter JM, Colditz GA, Huse DM, et al: Cimetidine and adverse reactions: A meta-analysis of randomized clinical trials of short-term therapy. Am J Med 1989; 87:278-284
32. Canti TG, Korek JS: Central nervous system reactions to histamine-2 receptor blockers. Ann Intern Med 1991; 114:1027-1034
33. McCarthy DM: Sucralfate. N Engl J Med 1991; 325:1017-1025
34. Craven DE, Kunches LM, Kilinsky V, et al: Risk factors for pneumonia and fatality in patients receiving continuous mechanical ventilation. Am Rev Respir Dis 1986; 133:792-796
35. Apte NM, Karnad DR, Medhekar TP, et al: Gastric colonization and pneumonia in intubated critically ill patients receiving stress ulcer prophylaxis: A randomized, controlled trial. Crit Care Med 1992; 20:590-593
36. Karlstadt RG, Herson J, Palmer R, et al: Cimetidine reduces upper gastrointestinal bleeding and nosocomial pneumonia in intensive care unit patients. Abstr. Am J Gastoenterol 1989; 84:93
37. Reusser P, Zimmerli W, Scheidegger D, et al: Role of gastric colonization in nosocomial infections and endotoxemia: A prospective study in neurosurgical patients on mechanical ventilation. J Infect Dis 1989; 160:414-421
38. Centers for Disease Control: CDC definitions for nosocomial infections 1988. Am Rev Respir Dis 1989; 139:1058-1059
39. Finkler SA: The distinction between cost and charges. Ann Intern Med 1982; 96:102-109
40. Redbook. 97th Edition. Mount Vale, NJ, Medical Economics Data Inc, 1993
41. Craven DE, Steger KA, Barber TW: Preventing nosocomial pneumonia: State of the art and perspectives for the 1990s. Am J Med 1991; 91(Suppl 3B)44S-53S
42. Meduri GU: Ventilator-associated pneumonia in patients with respiratory failure, a diagnostic approach. Chest 1990; 97:1208-1219
43. LaForce FM: Systemic antimicrobial therapy for nosocomial pneumonia. Eur J Clin Microbiol Infect Dis 1989; 8:61-68
44. Pennington J: Nosocomial respiratory infection. In: Principles and Practice of Infectious Disease. Mandel GL, Douglas RG Jr, Bennett JE (Eds). New York, Churchill Livingstone, 1990, pp 2199-2205
45. Freeman J, Rosner BA, McGowan JE Jr: Adverse effects of nosocomial infection. J Infect Dis 1979; 140:732-740
46. Craig CP, Connelly S: Effect of intensive care unit nosocomial pneumonia on duration of stay and mortality. Am J Infect Control 1984; 12:233-238
47. Leu HS, Kaiser DL, Mori M, et al: Hospital-acquired pneumonia; attributable mortality and morbidity. Am J Epidemiol 1989; 129:1258-1267
48. Wenzel RP: Hospital-acquired pneumonia: Overview of the current state of the art for prevention and control. Eur J Microbiol Infect Dis 1989; 8:56-60
49. Jiminez P, Torres A, Rodrigues-Roisin R, et al: Incidence and etiology of pneumonia acquired during mechanical ventilation. Crit Care Med 1989; 17:882-885
50. Rello J, Quintana E, Ausina V, et al: Incidence, etiology and outcome of nosocomial pneumonia in mechanically ventilated patients. Chest 1991; 100: 439-444
51. Eisenberg JM: Clinical economics, a guide to the economic analysis of clinical practices. JAMA 1989; 262:2879-2886
52. Tryba M, Zevounou F, Torok M, et al: Prevention of acute stress bleeding with sucralfate, antacids, or cimetidine. Am J Med 1985; 79(Suppl 2C):55S-61S
53. Cannon LA, Heiselman D, Gardner W, et al: Prophylaxis of upper gastrointestinal tract bleeding in mechanically ventilated patients. Arch Intern Med 1987; 147:2101-2106
54. Laggner AN, Lenz K, Base W, et al: Prevention of upper gastrointestinal bleeding in long term ventilated patients: Sucralfate versus ranitidine. Am J Med 1989; 86(Suppl 6A):81S-84S
55. Ryan P, Dawson J, Teres D, et al: Continuous infusion of cimetidine versus sucralfate: Incidence of pneumonia and bleeding compared. Abstr. Crit Care Med 1990; 18(Suppl):253
56. Kappstein I, Schulgen G, Friedrich T, et al: Incidence of pneumonia in mechanically ventilated patients treated with sucralfate or cimetidine as prophylaxis for stress bleeding: Bacterial colonization of the stomach. Am J Med 1991; 91(Suppl 2A):125S-131S
57. Eddleston JM, Vohra A, Scott P, et al: A comparison of the frequency of stress ulceration and secondary pneumonia in sucralfate- or ranitidine-treated intensive care unit patients. Crit Care Med 1991; 19:1491-1496
58. Pickworth KK, Falcone RF, Hoogeboom JE, et al: Occurrence of nosocomial pneumonia in mechanically ventilated patients: A comparison of sucralfate and ranitidine. Crit Care Med 1993; 21:1856-1862
59. Knaus WA, Wagner DP, Zimmerman JE, et al: Variations in mortality and length of stay in intensive care units. Ann Intern Med 1993; 118:753-761